Laboratory data showed thrombocytopenia (platelet count, 3.5 × 104/μL), abnormal coagulation factors (fibrinogen, 118 mg/dL; fibrin/fibrinogen degradation products (FDP), 126 μg/mL; D-dimer, 58.2 μg/mL; thrombin-antithrombin III complex (TAT), 25.3 μg/mL; plasmin-α2-antiplasmin complex (PIC), 8.5 μg/mL; antithrombin-III (AT-III), 114%); and a high level of brain-type natriuretic peptide (BNP). Here, SERPINC1 is linked to Thrombocytopenia.